Sumitomo Cost Of Revenue vs Ebitda Analysis

SUMICHEM

545.70 3.45 0.63%

Sumitomo Chemical financial indicator trend analysis is much more than just breaking down Sumitomo Chemical India prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Sumitomo Chemical India is a good investment. Please check the relationship between Sumitomo Chemical Cost Of Revenue and its Ebitda accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sumitomo Chemical India. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Cost Of Revenue vs Ebitda

Cost Of Revenue vs Ebitda Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Sumitomo Chemical India Cost Of Revenue account and Ebitda. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Sumitomo Chemical's Cost Of Revenue and Ebitda is 0.96. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Ebitda in the same time period over historical financial statements of Sumitomo Chemical India, assuming nothing else is changed. The correlation between historical values of Sumitomo Chemical's Cost Of Revenue and Ebitda is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Sumitomo Chemical India are associated (or correlated) with its Ebitda. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebitda has no effect on the direction of Cost Of Revenue i.e., Sumitomo Chemical's Cost Of Revenue and Ebitda go up and down completely randomly.

Correlation Coefficient

0.96

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Sumitomo Chemical India income statement and represents the costs associated with goods and services Sumitomo Chemical provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Ebitda

Most indicators from Sumitomo Chemical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Sumitomo Chemical India current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sumitomo Chemical India. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

The current year's Selling General Administrative is expected to grow to about 2.6 B, whereas Tax Provision is forecasted to decline to about 1.1 B.

	2021	2022	2023	2024 (projected)
Interest Expense	47.2M	53.9M	56.9M	40.7M
Depreciation And Amortization	448.1M	518.8M	621.9M	381.8M

Interest Expense Depreciation And Amortization

Sumitomo Chemical fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Current Deferred Revenue	Short Term Debt	Short Long Term Debt Total	Other Liab
Total Assets		0.93	0.93	0.99	0.98	0.3	0.72	0.86	0.12	0.92	0.1	0.83	0.94	-0.36	0.85	0.98	0.93	0.4	0.73	0.94	1.0	0.94	0.59	0.09	0.91	0.49
Other Current Liab	0.93		0.95	0.89	0.89	0.09	0.51	0.85	0.34	0.77	0.11	0.74	0.94	-0.26	0.83	0.92	0.91	0.33	0.54	0.96	0.95	0.94	0.7	-0.07	0.98	0.31
Total Current Liabilities	0.93	0.95		0.87	0.92	0.08	0.71	0.97	0.34	0.78	-0.02	0.68	0.98	-0.26	0.74	0.95	0.97	0.21	0.52	1.0	0.95	0.87	0.58	0.01	0.92	0.25
Total Stockholder Equity	0.99	0.89	0.87		0.97	0.37	0.69	0.79	0.02	0.94	0.15	0.85	0.89	-0.39	0.87	0.95	0.88	0.47	0.78	0.88	0.98	0.93	0.58	0.12	0.87	0.57
Property Plant And Equipment Net	0.98	0.89	0.92	0.97		0.36	0.76	0.88	0.05	0.89	0.06	0.79	0.94	-0.37	0.8	0.99	0.92	0.43	0.73	0.93	0.98	0.91	0.49	0.18	0.88	0.44
Net Debt	0.3	0.09	0.08	0.37	0.36		0.36	0.05	-0.87	0.45	-0.1	0.34	0.18	-0.38	0.29	0.27	0.24	0.22	0.53	0.1	0.25	0.18	-0.14	0.22	0.2	0.25
Retained Earnings	0.72	0.51	0.71	0.69	0.76	0.36		0.78	-0.08	0.74	-0.35	0.48	0.69	-0.34	0.37	0.74	0.74	0.03	0.52	0.71	0.69	0.5	0.07	0.2	0.47	0.32
Accounts Payable	0.86	0.85	0.97	0.79	0.88	0.05	0.78		0.35	0.71	-0.09	0.57	0.95	-0.25	0.6	0.9	0.94	0.12	0.46	0.97	0.88	0.77	0.44	0.12	0.81	0.15
Cash	0.12	0.34	0.34	0.02	0.05	-0.87	-0.08	0.35		-0.1	0.19	0.08	0.24	0.04	0.04	0.15	0.16	-0.1	-0.17	0.33	0.16	0.23	0.34	-0.09	0.25	-0.13
Non Current Assets Total	0.92	0.77	0.78	0.94	0.89	0.45	0.74	0.71	-0.1		0.11	0.75	0.81	-0.4	0.74	0.87	0.8	0.22	0.75	0.79	0.88	0.85	0.44	0.18	0.77	0.48
Non Currrent Assets Other	0.1	0.11	-0.02	0.15	0.06	-0.1	-0.35	-0.09	0.19	0.11		0.38	-0.02	-0.3	0.25	0.07	-0.08	0.23	0.27	-0.02	0.1	0.32	0.37	0.36	0.17	0.32
Cash And Short Term Investments	0.83	0.74	0.68	0.85	0.79	0.34	0.48	0.57	0.08	0.75	0.38		0.68	-0.74	0.79	0.78	0.67	0.59	0.91	0.69	0.82	0.82	0.5	0.25	0.76	0.7
Net Receivables	0.94	0.94	0.98	0.89	0.94	0.18	0.69	0.95	0.24	0.81	-0.02	0.68		-0.26	0.75	0.95	0.96	0.26	0.58	0.98	0.95	0.89	0.52	0.11	0.93	0.19
Common Stock Shares Outstanding	-0.36	-0.26	-0.26	-0.39	-0.37	-0.38	-0.34	-0.25	0.04	-0.4	-0.3	-0.74	-0.26		-0.2	-0.37	-0.24	-0.23	-0.75	-0.27	-0.35	-0.38	0.1	-0.56	-0.35	-0.42
Short Term Investments	0.85	0.83	0.74	0.87	0.8	0.29	0.37	0.6	0.04	0.74	0.25	0.79	0.75	-0.2		0.77	0.8	0.63	0.68	0.74	0.86	0.8	0.84	-0.19	0.79	0.58
Non Current Liabilities Total	0.98	0.92	0.95	0.95	0.99	0.27	0.74	0.9	0.15	0.87	0.07	0.78	0.95	-0.37	0.77		0.93	0.34	0.66	0.96	0.98	0.93	0.51	0.15	0.91	0.43
Inventory	0.93	0.91	0.97	0.88	0.92	0.24	0.74	0.94	0.16	0.8	-0.08	0.67	0.96	-0.24	0.8	0.93		0.25	0.55	0.97	0.94	0.81	0.62	-0.08	0.87	0.3
Other Current Assets	0.4	0.33	0.21	0.47	0.43	0.22	0.03	0.12	-0.1	0.22	0.23	0.59	0.26	-0.23	0.63	0.34	0.25		0.62	0.22	0.44	0.38	0.37	0.05	0.32	0.58
Other Stockholder Equity	0.73	0.54	0.52	0.78	0.73	0.53	0.52	0.46	-0.17	0.75	0.27	0.91	0.58	-0.75	0.68	0.66	0.55	0.62		0.53	0.7	0.67	0.25	0.43	0.59	0.61
Total Liab	0.94	0.96	1.0	0.88	0.93	0.1	0.71	0.97	0.33	0.79	-0.02	0.69	0.98	-0.27	0.74	0.96	0.97	0.22	0.53		0.95	0.88	0.58	0.02	0.92	0.26
Total Current Assets	1.0	0.95	0.95	0.98	0.98	0.25	0.69	0.88	0.16	0.88	0.1	0.82	0.95	-0.35	0.86	0.98	0.94	0.44	0.7	0.95		0.94	0.62	0.07	0.92	0.48
Common Stock	0.94	0.94	0.87	0.93	0.91	0.18	0.5	0.77	0.23	0.85	0.32	0.82	0.89	-0.38	0.8	0.93	0.81	0.38	0.67	0.88	0.94		0.59	0.2	0.95	0.42
Current Deferred Revenue	0.59	0.7	0.58	0.58	0.49	-0.14	0.07	0.44	0.34	0.44	0.37	0.5	0.52	0.1	0.84	0.51	0.62	0.37	0.25	0.58	0.62	0.59		-0.5	0.6	0.45
Short Term Debt	0.09	-0.07	0.01	0.12	0.18	0.22	0.2	0.12	-0.09	0.18	0.36	0.25	0.11	-0.56	-0.19	0.15	-0.08	0.05	0.43	0.02	0.07	0.2	-0.5		0.07	-0.09
Short Long Term Debt Total	0.91	0.98	0.92	0.87	0.88	0.2	0.47	0.81	0.25	0.77	0.17	0.76	0.93	-0.35	0.79	0.91	0.87	0.32	0.59	0.92	0.92	0.95	0.6	0.07		0.25
Other Liab	0.49	0.31	0.25	0.57	0.44	0.25	0.32	0.15	-0.13	0.48	0.32	0.7	0.19	-0.42	0.58	0.43	0.3	0.58	0.61	0.26	0.48	0.42	0.45	-0.09	0.25

Click cells to compare fundamentals

Sumitomo Chemical Account Relationship Matchups

Sumitomo Chemical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	21.1B	26.7B	30.1B	33.7B	33.1B	23.9B
Other Current Liab	3.3B	4.2B	4.2B	3.8B	3.1B	2.9B
Total Current Liabilities	8.4B	10.8B	10.2B	9.3B	8.0B	8.2B
Total Stockholder Equity	12.2B	15.4B	19.3B	23.8B	24.4B	15.3B
Property Plant And Equipment Net	3.2B	3.1B	4.1B	4.8B	5.0B	3.3B
Net Debt	(570.3M)	(1.8B)	(196.6M)	(129.2M)	(163.9M)	(172.1M)
Retained Earnings	1.1B	1.5B	1.6B	1.7B	2.3B	1.8B
Accounts Payable	4.9B	5.9B	5.2B	4.9B	4.3B	4.7B
Cash	926.1M	2.1B	572.5M	468.9M	466.4M	844.4M
Non Current Assets Total	3.6B	3.7B	4.9B	5.8B	6.4B	4.4B
Non Currrent Assets Other	295.9M	175.7M	95.3M	86.9M	543.5M	570.7M
Cash And Short Term Investments	1.8B	5.3B	5.8B	8.3B	10.3B	10.8B
Net Receivables	8.8B	8.6B	8.5B	9.5B	7.2B	7.2B
Short Term Investments	862.1M	3.2B	5.2B	7.8B	3.5B	2.5B
Liabilities And Stockholders Equity	21.1B	26.7B	30.1B	33.7B	33.1B	23.9B
Non Current Liabilities Total	445.4M	495.8M	609.7M	539.3M	680.2M	428.6M
Inventory	5.9B	7.5B	9.4B	8.9B	6.1B	6.8B
Other Current Assets	1.3B	1.7B	1.6B	3.8B	3.1B	2.0B
Total Liab	8.8B	11.3B	10.8B	9.9B	8.7B	8.6B
Total Current Assets	17.5B	23.0B	25.2B	27.9B	26.7B	19.5B
Accumulated Other Comprehensive Income	(977.6M)	6.6B	10.3B	14.8B	67.9M	64.5M
Current Deferred Revenue	(161.8M)	3.6B	4.1B	3.8B	434.3M	412.5M
Short Term Debt	161.8M	(372.3M)	(573.8M)	(276.0M)	117.4M	123.2M
Short Long Term Debt Total	355.8M	326.4M	375.8M	339.7M	302.5M	314.1M
Other Liab	302.3M	251.4M	342.4M	362.5M	416.9M	348.5M
Net Tangible Assets	10.4B	12.2B	15.3B	19.1B	22.0B	14.6B
Other Assets	321.2M	425.6M	385.7M	435.9M	501.3M	417.6M
Long Term Debt Total	194M	153.3M	247.2M	177.5M	204.1M	141.5M
Deferred Long Term Liab	18.0M	14.4M	5.0M	6.7M	6.0M	9.0M
Net Invested Capital	12.2B	15.4B	19.3B	23.8B	24.4B	18.1B
Net Working Capital	9.1B	12.3B	15.0B	18.5B	18.7B	13.8B
Intangible Assets	54.8M	105.7M	184.6M	215.5M	247.7M	147.7M
Property Plant Equipment	3.2B	3.1B	4.1B	4.8B	5.5B	3.8B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Other Information on Investing in Sumitomo Stock

Balance Sheet is a snapshot of the financial position of Sumitomo Chemical India at a specified time, usually calculated after every quarter, six months, or one year. Sumitomo Chemical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Sumitomo Chemical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Sumitomo currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Sumitomo Cost Of Revenue vs Ebitda Analysis

Cost Of Revenue vs Ebitda

Cost Of Revenue vs Ebitda Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Ebitda

Sumitomo Chemical fundamental ratios Correlations

Sumitomo Chemical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Sumitomo Chemical fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Sumitomo Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Total Stockholder Equity	+ 0.99	Total Assets
Non Current Liabilities Total	+ 0.99	Property Plant And Equipment Net
Property Plant And Equipment Net	+ 0.98	Total Assets
Non Current Liabilities Total	+ 0.98	Total Assets

Cash	- 0.87	Net Debt
Other Stockholder Equity	- 0.75	Common Stock Shares Outstanding
Common Stock Shares Outstanding	- 0.74	Cash And Short Term Investments
Short Term Debt	- 0.56	Common Stock Shares Outstanding
Short Term Debt	- 0.5	Current Deferred Revenue
Other Liab	- 0.42	Common Stock Shares Outstanding